Minimally Invasive Surgery for Diabetic Foot Reconstruction

Abstract

Minimally invasive surgery (MIS) has emerged as a critical innovation in the management of diabetic foot complications, offering reduced morbidity and improved functional outcomes compared to traditional open procedures. This review synthesizes current evidence regarding the indications, techniques, clinical outcomes, and future perspectives of MIS in diabetic foot reconstruction. Emphasis is placed on the epidemiological context, pathophysiological mechanisms, and risk stratification to guide clinicians in patient selection and perioperative management. The article integrates recent advances, guideline recommendations, and expert insights to support evidence-based decision-making in this challenging patient population.

Introduction

Diabetic foot complications represent a significant source of morbidity and healthcare burden worldwide, with limb-threatening infections and structural deformities frequently necessitating surgical intervention. The advent of minimally invasive surgery offers a paradigm shift in the surgical approach to diabetic foot reconstruction. Unlike traditional open procedures, MIS techniques aim to achieve the same therapeutic objectives—debridement, realignment, stabilization—while minimizing soft tissue disruption, thereby reducing wound complications, promoting faster recovery, and preserving foot function. This review provides an in-depth examination of MIS applications in diabetic foot reconstruction for clinicians seeking to optimize patient outcomes through evidence-based and guideline-concordant care.

Epidemiology / Disease Burden

Globally, an estimated 463 million adults are living with diabetes, and up to 25% will develop a foot ulcer during their lifetime. Diabetic foot complications are the leading cause of non-traumatic lower extremity amputations, with annual incidences ranging from 0.2% to 2% in the diabetic population. The burden is particularly pronounced in patients with longstanding diabetes, peripheral neuropathy, and vascular disease, leading to prolonged hospitalizations, high healthcare costs, and reduced quality of life. The increasing prevalence of diabetes underscores the need for effective surgical strategies that minimize complications and preserve limb integrity.

Pathophysiology

The pathogenesis of diabetic foot complications is multifactorial, involving peripheral neuropathy, peripheral arterial disease, immunopathy, and biomechanical abnormalities. Neuropathy leads to loss of protective sensation and foot deformities, while microvascular and macrovascular disease impair tissue perfusion and healing capacity. Repetitive trauma and impaired wound healing create a permissive environment for infection, osteomyelitis, and progressive tissue necrosis. Biomechanical instability from Charcot neuroarthropathy or tendon imbalance further exacerbates the risk of ulceration and structural compromise, often necessitating surgical intervention.

Risk Factors

Risk factors for diabetic foot complications include poor glycemic control, duration of diabetes, prior ulceration or amputation, peripheral neuropathy, peripheral arterial disease, foot deformities (e.g., Charcot foot, hammertoes), and limited joint mobility. Additional contributors include impaired immune function, chronic kidney disease, and inadequate patient education regarding foot care. Identifying and stratifying these risk factors is essential for preventive strategies and surgical planning, particularly when considering the suitability of MIS approaches.

Clinical Features

Clinical presentation varies from superficial ulcerations to deep tissue infection, abscess formation, osteomyelitis, and structural deformities such as Charcot neuroarthropathy. Patients may present with erythema, swelling, drainage, malodor, and, in severe cases, systemic signs of infection. Deformities can lead to abnormal weight-bearing, callus formation, and recurrent ulceration. Accurate assessment of vascular status, sensation, and structural integrity is crucial for guiding management and surgical decision-making.

Diagnosis

Diagnosis is based on a combination of clinical evaluation, laboratory markers, and imaging studies. Probing to bone, elevated inflammatory markers, and advanced imaging (MRI, CT) help delineate the extent of soft tissue and bony involvement. Vascular assessment using ankle-brachial index, toe pressures, and duplex ultrasonography is essential, as is the evaluation of infection severity and identification of underlying deformities. Multidisciplinary assessment is recommended for comprehensive care planning.

Treatment & Management

The management of diabetic foot complications is multimodal, encompassing glycemic control, infection eradication, vascular optimization, offloading, and wound care. Surgical intervention becomes necessary in the presence of deep infection, nonhealing ulcers, osteomyelitis, or gross structural instability. MIS techniques—such as percutaneous tenotomy, minimally invasive osteotomy, arthrodesis, and soft tissue release—are increasingly favored for select indications. These procedures aim to correct deformities, promote ulcer healing, and stabilize the foot with minimal tissue disruption, thus reducing postoperative wound complications and facilitating early mobilization.

Recent Advances / Emerging Therapies

Recent advances in MIS for diabetic foot reconstruction include the use of fluoroscopic and endoscopic guidance, novel fixation devices (locking plates, intramedullary screws), and biologic adjuncts to enhance healing. Techniques such as percutaneous Achilles tendon lengthening, minimally invasive correction of metatarsal deformities, and endoscopic plantar fascia release have demonstrated efficacy in reducing ulcer recurrence and improving functional outcomes. Emerging therapies also encompass the use of growth factors, stem cell therapy, and negative pressure wound therapy in conjunction with MIS approaches. The integration of computer-assisted planning and intraoperative imaging is poised to further enhance precision and outcomes.

Guideline Recommendations

Current guidelines from the International Working Group on the Diabetic Foot (IWGDF) and other expert panels endorse a multidisciplinary approach, emphasizing the role of individualized surgical planning. MIS is recommended for patients with isolated deformities, nonhealing ulcers refractory to conservative care, and those at high risk for wound complications following open surgery. Patient selection, perioperative glycemic control, and optimization of vascular status are crucial for minimizing complications. Formal protocols for postoperative offloading and wound surveillance are integral to long-term success and limb preservation.

Conclusion

Minimally invasive surgery represents a significant advancement in the surgical management of diabetic foot complications, offering reduced morbidity, shorter recovery times, and improved preservation of limb function. Careful patient selection, adherence to guideline-based perioperative protocols, and the integration of emerging technologies are fundamental to optimizing outcomes. As the prevalence of diabetes rises globally, MIS will play an increasingly central role in limb salvage strategies, underscoring the need for ongoing research, multidisciplinary collaboration, and clinician education.